Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study

BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality, being twofold to fourfold more common in patients with type 2 diabetes mellitus (T2DM) than in individuals without diabetes. However, despite this decade-old knowledge, the identification of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruscica, Massimiliano, Macchi, Chiara, Giuliani, Angelica, Rizzuto, Alessandra Stefania, Ramini, Deborah, Sbriscia, Matilde, Carugo, Stefano, Bonfigli, Anna Rita, Corsini, Alberto, Olivieri, Fabiola, Sabbatinelli, Jacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464486/
https://www.ncbi.nlm.nih.gov/pubmed/37620933
http://dx.doi.org/10.1186/s12933-023-01948-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464486/
https://www.ncbi.nlm.nih.gov/pubmed/37620933
http://dx.doi.org/10.1186/s12933-023-01948-8

Ejemplares similares